Actorius Unveils NGS Genomic Tests and OncoDiscover CTC Biomarker Platform at ACTREC’s CAMO 2026
Oct 27, 2026
New Delhi [India], October 27: Actorius Innovations and Research today presented its integrated liquid biopsy portfolio at the CAMO 2026 – Cancer in Motion International Scientific Symposium held at ACTREC, Tata Memorial Centre, Navi Mumbai. At the event, the company launched its next-generation sequencing genomic tests designed to guide cancer treatment decisions, while highlighting the complementary role of its CDSCO-approved OncoDiscover circulating tumor cell biomarker technology.
Read More ..